Nothing Special   »   [go: up one dir, main page]

Beloborodov et al., 2021 - Google Patents

Knottins As A Structural Basis For The Stabilization Of Radio Pharmaceuticals

Beloborodov et al., 2021

View PDF
Document ID
737187919266083351
Author
Beloborodov E
Iurova E
Rastorgueva E
Pogodina E
Saenko Y
Fomin A
Publication year
Publication venue
NVEO-NATURAL VOLATILES & ESSENTIAL OILS Journal| NVEO

External Links

Snippet

The aim of the current reseach was to study synthesize a peptide tropic to the prostate- specific antigen and containing a cysteine knot. Materials and Methods: A comparative study of the efficiency of binding in vitro with prostate cancer cells of artificial peptides based on …
Continue reading at www.nveo.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/082—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30—Macromolecular compounds
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein

Similar Documents

Publication Publication Date Title
Däpp et al. PEGylation of 99mTc-labeled bombesin analogues improves their pharmacokinetic properties
CA3033004A1 (en) Stable peptides and methods of use thereof
JP2008539209A (en) Diagnostic and therapeutic agents
Psimadas et al. Synthesis and comparative assessment of a labeled RGD peptide bearing two different 99mTc-tricarbonyl chelators for potential use as targeted radiopharmaceutical
Grob et al. Design of radiolabeled analogs of minigastrin by multiple amide-to-triazole substitutions
Kim et al. Synthesis of Tc-99m labeled 1, 2, 3-triazole-4-yl c-met binding peptide as a potential c-met receptor kinase positive tumor imaging agent
Baishya et al. Synthesis, Characterization, and Biological Evaluation of 99m T c (CO) 3‐Labeled Peptides for Potential Use as Tumor Targeted Radiopharmaceuticals
García Boy et al. Sunflower trypsin inhibitor 1 derivatives as molecular scaffolds for the development of novel peptidic radiopharmaceuticals
Beloborodov et al. Knottins As A Structural Basis For The Stabilization Of Radio Pharmaceuticals
Iurova et al. PSMA-Specific Peptide with Inhibitor Cystine Knot for Prostate Cancer Treatment.
CA3171753A1 (en) Stable formulations for radionuclide complexes
JP2023520769A (en) Selective GIP receptor agonists containing chelating moieties for imaging and therapeutic purposes
Mikaeili et al. Synthesis and evaluation of a 99mTc-labeled chemokine receptor antagonist peptide for imaging of chemokine receptor expressing tumors
Ben Azzouna et al. Synthesis, gallium labelling and characterization of P04087, a functionalized phosphatidylserine-binding peptide
De et al. Synthesis and exploration of novel radiolabeled bombesin peptides for targeting receptor positive tumor
Brans et al. Glycation methods for bombesin analogs containing the (NαHis) Ac chelator for 99mTc (CO) 3 radiolabeling
Simpson et al. Investigation of isomer formation upon coordination of bifunctional histidine analogues with 99m Tc/Re (CO) 3
US20130323171A1 (en) Radiolabeled bbn analogs for pet imaging of gastrin-releasing peptide receptors
Sharma et al. Design, synthesis and evaluation of 177Lu-labeled inverso and retro-inverso A9 peptide variants targeting HER2-overexpression
Vats et al. Design, synthesis, and comparative evaluation of 99mTc (CO) 3‐labeled N‐terminal and C‐terminal modified asparagine–glycine–arginine peptide constructs
Murce et al. Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkers
Marciniak et al. The Analysis of the Structural Aspects of Cu (II) Binding by Cyclic His/Asp-Analogues of Somatostatin
Vats et al. 68Ga-labeled HBED-CC variant of uPAR targeting peptide AE105 compared with 68Ga-NODAGA-AE105
Farzipour et al. Correlation between in vitro and in vivo data of radiolabeled peptide for tumor targeting
Klimentzou et al. Solid‐phase Synthesis of a Peptide Derivative of Thymosin alpha1 and Initial Studies on its 99mTc‐Radiolabelling